Lycera Corp.   Report issue

For profit Phase 1 Phase 2
Founded: Ann Arbor MI United States (2006)
Status: Defunct (2021)

Organization Overview

First Clinical Trial
2016
NCT02818543
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Lycera Corp.